UB-421: Clinical Trials

3 trials of UB-421, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow UB-421: new trials by email Literature Review of UB-421 trials Research Report on UB-421

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Proof-of-concept Trial to Evaluate the Safety and Efficacy of UB-421 Plus Chidamide in Changing HIV Reservoirs
UB-421, chidamide - HIV-1 Infection
Phase 2CompletedUnited BioPharma112021-12-022023-02-15
The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients
UB-421(25 mg/kg) Q2W, UB-421(25 mg/kg) Q4W - HIV-1 Infection
Phase 2CompletedUnited BioPharma312018-12-122022-05-13
To Investigate the Safety and Efficacy of UB-421 Monotherapy in HIV Infected Adults
UB-421 - HIV-1 Infection
Phase 2CompletedUnited BioPharma292015-06-012017-10-31

Sponsors

United BioPharma (3)

Countries

Taiwan (3)

Top investigators

Hung Chin Tsai, M.D. PhD. (1)  ·  Wing Wai Wong, M.D. (1)  ·  Yen Hsu Chen, M.D. PhD. (1)

Results publications

PMID 30995373